PULM
Pulmatrix, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Aug 13 M&A: Pulmatrix Announces Second Quarter 2026 Financial Results…
- Aug 13 ▼ Pulmatrix reported Q2 2026 financial results with minimal revenue, a…
- Aug 14 ▲ Short interest falls 75.2% to 4.2K
- Aug 31 ▼ Short interest jumps 384.3% to 20.2K
- Sep 4 ▼ Pulmatrix filed Amendment No. 2 to its S-4 registration statement, a…
- Sep 15 ▼ Short interest jumps 174.2% to 55.4K
- Sep 25 ▼ Pulmatrix is asking stockholders to vote on a reverse merger with Eo…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q3 2026: 0 added (0 new), 2 trimmed or exited.
- Short sellersSTEADY
Short interest −8.5% to 39.5K shares. 1.3 days to cover, ≈1.1% of shares.
- TrendDOWNTREND
9% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | NEAR_EXIT | $15.00 |
| BARCLAYS PLC | TRIM | $7.00 |
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $56.6K |
| UBS Group AG | DOUBLED | $875.00 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $3.0K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | NEAR_EXIT | $2.00 |
| UBS Group AG | NEAR_EXIT | $627.00 |
| UBS Group AG | DOUBLED | $37.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2023| Date | Firm | Rating |
|---|---|---|
| Aug 15, 2023 | HC Wainwright & Co. REITERATE | Buy |
| May 15, 2023 | HC Wainwright & Co. REITERATE | Buy |
| Feb 7, 2023 | HC Wainwright & Co. REITERATE | Buy |
| Mar 30, 2022 | HC Wainwright & Co. MAINTAIN | Buy |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 1 press release · 0 bullish · 7 bearish · 13 neutral- NEUTRAL 425Nov 9, 2026
Eos SENOLYTIX announced new preclinical data for PTC-2105 showing it reduced…
Monitor for the December 2026 conference presentation and any updates on Nasdaq listing approval, which is the remaining condition for merger close.
- NEUTRAL 425Oct 30, 2026
Eos SENOLYTIX reported early interim preclinical data for PTC-2105 in aged rats, showing preserved…
The merger is on track for closing, but the preclinical data are too preliminary to affect valuation. Monitor for IND submission and first-in-human trial initiation in 2027, as well as any…
- BEARISH EFFECTOct 23, 2026
The SEC declared effective Pulmatrix's S-3 shelf registration (File No. 333-296478) on October 22…
The effectiveness of this shelf registration enables the selling stockholder to begin reselling shares immediately, creating near-term selling pressure on an already thinly traded micro-cap. Monitor…
- NEUTRAL 425Oct 22, 2026
Eos SENOLYTIX presented positive preclinical survival and healthspan data for PTC-2105 at a…
The merger vote is the next key catalyst on October 26. Monitor for any last-minute opposition or changes in shareholder sentiment. The preclinical data is supportive but early-stage; focus on the…
All PULM filing & press-release reports (21)
- 425 reportNov 9, 2026
- 425 reportOct 30, 2026
- EFFECT reportOct 23, 2026
- 425 reportOct 22, 2026
- 425 reportOct 13, 2026
- DEFA14A reportOct 7, 2026
- S-3/A reportOct 2, 2026
- EFFECT reportSep 28, 2026
- DEFM14A reportSep 25, 2026
- S-4/A reportSep 23, 2026
- 425 reportSep 22, 2026
- S-4/A reportSep 17, 2026
- S-4/A reportSep 4, 2026
- 8-K reportAug 13, 2026
- PRESS-RELEASE reportAug 13, 2026
- S-3/A reportAug 7, 2026
- 10-K/A reportJun 16, 2026
- 425 reportJun 5, 2026
- S-3 reportJun 4, 2026
- 8-K reportMay 15, 2026
- 8-K reportApr 21, 2026